Key facts
- This page summarizes Michael J. Carson's Form 4 filing for Nuvectis Pharma, Inc. (NVCT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Jan 2025, 18:10.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
The 51,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates.
Footnote F2
Includes 138,918 shares of restricted common stock.